|
221 Pseudoephedrine
products remain OTC, but with new pack size limits Products
containing pseudoephedrine and ephedrine will remain available over the
counter, the Medicines and Healthcare products Regulatory Agency has
decided. However, pack sizes will be restricted to 720mg and sales limited
to one pack per customer, to be carried out by a pharmacist
PJ 2007;279:221
Full Text
221 Dispensing doctors defend prescription
record The Dispensing Doctors' Association
has this week defended its prescribing track record with new figures
suggesting that medicines dispensed by its members cost the NHS less
than those dispensed by community pharmacists. But the Pharmaceutical
Services Negotiating Committee said that the figures should be viewed
with caution
PJ 2007;279:221
Full Text
221 Restrictions for lumiracoxib in wake of
liver concerns New contraindications and monitoring
advice for lumiracoxib (Prexige) have been issued by Novartis, the drug's manufacturer
PJ 2007;279:221
Full Text
221 BNF and BNF-C on mobiles The
latest editions of the electronic British National Formulary and its sister publication
the British National Formulary for Children are available for use with a range
of mobile devices and are now on both Skyscape and Medhand mobile platforms
PJ 2007;279:221
Full Text
222 Pharmacists target children
in “get fit” campaign Pharmacists
in Suffolk have been offering advice to families as part of a campaign to improve
the health of children
PJ 2007;279:222
Full Text
222 Study confirms calcium's value in reducing
risk of osteoporotic fracture and bone loss Calcium,
alone or in combination with vitamin D, can reduce the risk of osteoporotic fracture
and bone loss, a meta-analysis published confirms
PJ 2007;279:222
Full Text
222 Optometrists join ranks of independent prescribers Optometrists
are to be given powers to prescribe independently, health minister Dawn Primarolo
announced earlier this week
PJ 2007;279:222
Full Text
222 Impact on pharmacy of GPs in Scotland opting
out of 24-hour care highlighted Out-of-hours services
in Scotland are under pressure and new ways of working need to be found. This
is the conclusion of a report published this week by Audit Scotland
PJ 2007;279:222
Full Text
223 Pan-pharmacy group to
consult on NHS IT matters A group that aims to
ensure the pharmacy profession is fully engaged with all relevant programmes
within NHS Connecting for Health has been formed
PJ 2007;279:223
Full Text
223 Health inequalities targeted with intervention
tool available online An interactive tool to help
primary care trusts, practice-based commissioners and local councils improve
life expectancy has been launched by the Department of Health
PJ 2007;279:223
Full Text
223 UK cancer survival remains behind leaders
on the continent Cancer survival rates in the UK
are still lagging behind Europe's best performing countries, two studies published
online suggest
PJ 2007;279:223
Full Text
223 Health mapping in Wales A
web-based health mapping tool has been developed by the health information analysis
team of the National Public Health Service for Wales
PJ 2007;279:223
Full Text
223 BOPA website The
British Oncology Pharmacy Association has launched a new website
PJ 2007;279:223
Full Text
224 Plans laid for trials
of emergency care medicines to treat children Research
into emergency care for children will no longer require prior authorisation if
legislative amendments proposed by the Medicines and Healthcare products Regulatory
Agency are adopted
PJ 2007;279:224
Full Text
224 WHO report highlights public health security Global co-operation, collaboration and investment are necessary to ensure a safe future, the World Health Organization concludes in this year’s World Health Report “A safer future: global public health security in the 21st century”
PJ 2007;279:224
Full Text
224 MHRA issues Chinese medicine warning about
aristolochia A warning about traditional Chinese
medicines found to contain aristolochia has been issued by the Medicines and
Healthcare products Regulatory Agency following the purchase of Xie Gan Wan pills
from a Chinese herbalist in South Wales. The use of aristolochia, which is associated
with kidney failure and cancer, has been prohibited in unlicensed medicines since
1999
PJ 2007;279:224
Full Text
224 Phase I trial guidance published by industry New
guidelines for phase I clinical trials have been published by the Association
of the British Pharmaceutical Industry
PJ 2007;279:224
Full Text
224 Lloyds avoids competition referral Lloydspharmacy's
acquisition of Independent Pharmacy Care Centres will not be referred to the
Competition Commission
PJ 2007;279:224
Full Text
224 Pandemic influenza contracts Advanced
supply contracts to provide a vaccine for pandemic influenza have been awarded
by the Department of Health to GlaxoSmithKline and Baxter Healthcare
PJ 2007;279:224
Full Text
224 Pharmacy education innovation Developments
in pharmacy education are to be shared in a compendium of research projects commissioned
by the Pharmacy Practice Research Trust
PJ 2007;279:224
Full Text |
The
Pharmaceutical Journal